Invivoscribe’s LabPMM Gains New York State Approval for the FLT3 ITD MRD Assay
Invivoscribe is proud to announce that its wholly owned subsidiary, the Laboratory for Personalized Molecular Medicine® (LabPMM), LLC has received approval from the New York State...